CompanyGraph
At a glance
- Depends onUpstream position: supplies 4 industries, depends on 2
- ScaleRevenue is $5.3B, above the global median of $520.53M
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
286.19MUSDvs all stocks (USD)
Revenue (TTM)
5.30BUSDvs all stocks (USD)
Profit Margin
-1.60%Beta
2.40xvs all stocks
52-Week Change
-75.60%vs all stocks
Market Capitalization
286.19MUSDvs all stocks (USD)
Enterprise Value
2.30BUSDvs all stocks (USD)
Forward P/E
20.59xPrice to Sales (TTM)
0.0540xPrice to Book (MRQ)
0.3524xEnterprise to Revenue
0.4340xEnterprise to EBITDA
-16.49xGross Margin
7.55%Profit Margin
-1.60%Operating Margin
-0.58%Return on Assets (TTM)
-2.51%Return on Equity (TTM)
-5.72%Revenue (TTM)
5.30BUSDvs all stocks (USD)
Revenue per Share (TTM)
180.19USDUpdated Jul 18, 2026Quarterly Revenue Growth
39.80%Gross Profit (TTM)
236.42MUSDvs all stocks (USD)
EBITDA (TTM)
0.00USDvs all stocks (USD)
Net Income (TTM)
-84.86MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
278.07%Operating Cash Flow (TTM)
-488.70MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-131.16MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
-15.59MUSDFY2024 · Dec 31, 2024Revenue
1.62BUSDFY2024 · Dec 31, 2024Cost of Goods Sold
1.42BUSDFY2024 · Dec 31, 2024Gross Profit
203.91MUSDFY2024 · Dec 31, 2024Operating Income
-192.21MUSDvs all stocks (USD)
Pre-tax Income
-177.12MUSDFY2024 · Dec 31, 2024Income Tax Expense
659.00KUSDFY2024 · Dec 31, 2024Net Income
-176.09MUSDFY2024 · Dec 31, 2024EBIT
-156.27MUSDFY2024 · Dec 31, 2024EBITDA (Income Statement)
-139.43MUSDFY2024 · Dec 31, 2024Research & Development
80.01MUSDFY2024 · Dec 31, 2024Selling, General & Administrative
277.56MUSDFY2024 · Dec 31, 2024Non-operating Interest Income
8.38MUSDFY2024 · Dec 31, 2024Non-operating Interest Expense
20.85MUSDFY2024 · Dec 31, 2024EPS (Basic)
-0.5400USDFY2024 · Dec 31, 2024EPS (Diluted)
-0.5400USDFY2024 · Dec 31, 2024Basic Shares Outstanding
319.65MSharesFY2024 · Dec 31, 2024Diluted Shares Outstanding
319.65MSharesFY2024 · Dec 31, 2024Net Income from Continuing Operations
-177.78MUSDFY2024 · Dec 31, 2024Minority Interests (P&L)
3.84MUSDFY2024 · Dec 31, 2024Operating Cash Flow
-86.60MUSDFY2024 · Dec 31, 2024Free Cash Flow
-89.33MUSDDerived from operating cash flow minus capital expenditure. This filing charges 42.54M of depreciation against 2.73M of capital expenditure, and its own free-cash-flow line reads -95.31M.FY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
167.57MUSDFY2024 · Dec 31, 2024Income Tax Paid
251.00KUSDFY2024 · Dec 31, 2024Interest Paid
14.94MUSDFY2024 · Dec 31, 2024Starting Profit (CF Statement)
-177.78MUSDFY2024 · Dec 31, 2024Depreciation & Amortization
42.54MUSDFY2024 · Dec 31, 2024Deferred Taxes (CF)
218.00KUSDFY2024 · Dec 31, 2024Stock-based Compensation
42.51MUSDFY2024 · Dec 31, 2024Other Non-cash Items
-524.00KUSDFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
9.03MUSDFY2024 · Dec 31, 2024Change in Accounts Payable (CF)
-5.75MUSDFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
3.15MUSDFY2024 · Dec 31, 2024Capital Expenditures
-2.73MUSDFY2024 · Dec 31, 2024Net Intangibles (CF)
-1.64MUSDFY2024 · Dec 31, 2024Net Acquisitions
0.00USDFY2024 · Dec 31, 2024Purchase of Investments
0.00USDFY2024 · Dec 31, 2024Sale of Investments
0.00USDFY2024 · Dec 31, 2024Net Investing Cash Flow
-2.73MUSDFY2024 · Dec 31, 2024Long-term Debt Payments
-26.97MUSDFY2024 · Dec 31, 2024Common Dividends Paid
0.00USDFY2024 · Dec 31, 2024Net Financing Cash Flow
16.32MUSDFY2024 · Dec 31, 2024Shares Outstanding
29.44MSharesUpdated Jul 18, 2026Float Shares
29.18MSharesUpdated Jul 18, 2026Shares Short
7.00MSharesUpdated Jul 18, 2026Short Ratio
4.51daysvs all stocks
Short % of Shares Outstanding
24.14%vs all stocks
% Held by Insiders
4.05%vs all stocks
% Held by Institutions
46.73%vs all stocks
Total Cash (MRQ)
237.81MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
8.08USDUpdated Jul 18, 2026Total Debt (MRQ)
408.23MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1538xCurrent Ratio (MRQ)
0.9940xBook Value per Share (MRQ)
27.59USDUpdated Jul 18, 2026Total Assets
1.08BUSDvs all stocks (USD)
Total Current Assets
274.03MUSDFY2024 · Dec 31, 2024Total Liabilities
896.65MUSDFY2024 · Dec 31, 2024Total Non-current Assets
803.39MUSDFY2024 · Dec 31, 2024Total Non-current Liabilities
381.32MUSDFY2024 · Dec 31, 2024Total Current Liabilities
515.32MUSDFY2024 · Dec 31, 2024Cash & Cash Equivalents
161.44MUSDFY2024 · Dec 31, 2024Accounts Receivable
71.08MUSDFY2024 · Dec 31, 2024Accounts Payable
67.84MUSDFY2024 · Dec 31, 2024Short-term Debt
13.09MUSDFY2024 · Dec 31, 2024Deferred Revenue
98.42MUSDFY2024 · Dec 31, 2024Long-term Debt
365.33MUSDFY2024 · Dec 31, 2024Other Non-current Liabilities
15.99MUSDFY2024 · Dec 31, 2024Common Stock (Book)
34.00KUSDFY2024 · Dec 31, 2024Retained Earnings
-2.02BUSDFY2024 · Dec 31, 2024Total Shareholders' Equity
180.78MUSDvs all stocks (USD)
52-Week Low
7.95USDUpdated Jul 18, 202652-Week High
56.64USDUpdated Jul 18, 202652-Week Change
-75.60%vs all stocks
Beta
2.40xvs all stocks
50-Day MA
9.74USDUpdated Jul 18, 2026200-Day MA
22.95USDUpdated Jul 18, 2026Avg 10-Day Volume
1.42MSharesUpdated Jul 18, 2026Avg 30-Day Volume
1.51MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
3.84USDUpdated Jul 18, 2026Other Income / Expense
27.56MUSDFY2024 · Dec 31, 20243 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Asset Growth With a Recent Reversal
Assets grew over the long run on acquired goodwill, but have shrunk in each of four years.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 4 industries, depends on 2Notable
Outgoing: 4.00Incoming: 2.00
Scale
Revenue is $5.3B, above the global median of $520.53MNotable
Revenue (USD): 5,304,069,120Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
The E.W. Scripps Company
Tier 1AttentionPerishable CapacityInterfaceFlow
Keep Inc.
Tier 1AttentionPerishable CapacityInterfaceSenseMaking
Wowow Inc.
Tier 1AttentionPerishable CapacityFlowInterface
Tvzone Media Co. Ltd.
Tier 1AttentionPerishable CapacityFlowProduction
Aeon Fantasy Co., Ltd.
Tier 1AttentionPerishable CapacityInterfaceFlow
Asahi Broadcasting Group Holdings Corporation
Tier 1AttentionPerishable CapacityFlowInterface
Holiday Entertainment Co. Ltd.
Tier 1AttentionPerishable CapacityRuleFlow
Gray Television, Inc.
Tier 1AttentionPerishable CapacityInterfaceFlow
Ihlas Haber Ajansi A.S.
Tier 1AttentionPerishable CapacityFlowSenseMaking
Holmes Place International Ltd.
Tier 1AttentionPerishable CapacityFlowInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Eos Energy Enterprises Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Defi Technologies Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Fulcrum Therapeutics Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown